Evidence-based guides to help you understand, start, and thrive on GLP-1 medications.
The FDA just approved Wegovy HD — semaglutide at 7.2mg, triple the standard dose. With 20.7% mean weight loss, it closes the gap with tirzepatide. Here's everything you need to know.
Retatrutide, orforglipron, CagriSema, aleniglipron — the next generation of obesity medications is closer than you think. Here's what's in the pipeline and when to expect it.
The US patent on semaglutide expired on March 20, 2026. Cheaper generic versions are legally on the way. Here's what you need to know about timing, pricing, safety, and what this means for your treatment.
Some people report improved sexual function on GLP-1 medications. Others report the opposite. The research explains why both experiences are valid — and what drives the difference.
PCOS and obesity are deeply intertwined, and GLP-1 medications may help with both. Here's what the research says about semaglutide, tirzepatide, and polycystic ovary syndrome.
Tirzepatide is now FDA-approved for obstructive sleep apnoea. Semaglutide shows similar benefits. Here's what the research says about GLP-1 medications and sleep-disordered breathing.
The constant mental chatter about food that dominates your day has a name — food noise. GLP-1 medications like Ozempic and Mounjaro can dramatically reduce it. Here's the science and the experience.
Something unexpected happens when many people start Ozempic, Wegovy, or Mounjaro — they lose interest in drinking. The science behind it is fascinating, and the safety implications are real.
When your appetite is suppressed and you're eating 1,200-1,500 calories a day, protein powder isn't a luxury — it's a necessity. Here's what to look for and what to avoid.
Losing muscle on Ozempic or Mounjaro is a valid worry. The data says 25% of weight lost is lean mass — roughly the same as any diet. But that doesn't mean you should accept it. Here's exactly how to fight back.
Your appetite has changed and every bite matters more than it used to. Here's how to eat well on Ozempic, Wegovy, Mounjaro, or any GLP-1 — with protein targets, meal ideas, and what to avoid.
The first GLP-1 pill for weight loss is here. Oral semaglutide launched in January 2026 at $149-$299/month. Here's how it works, what to expect, and how it compares to the injection.
People on GLP-1 medications are reporting they've lost interest in cigarettes alongside food cravings. Early research suggests this isn't coincidence — the same brain pathways are involved.
Do Ozempic and Mounjaro cause depression? Suicidal thoughts? Or do they actually improve mental health? The evidence is more nuanced — and more reassuring — than the headlines suggest.
Semaglutide is now FDA-approved for MASH — the liver condition affecting millions. Here's what fatty liver disease is, how GLP-1 medications help, and what this means for your treatment.
Thinking about stopping Ozempic, Wegovy, or Mounjaro? The data on what happens next is sobering but important. Here's what clinical trials and real experience tell us.
Your first dose is sitting on the counter and you're full of questions. This week-by-week guide walks you through exactly what happens when you start Ozempic, Wegovy, Mounjaro, or any GLP-1 medication.
GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have changed weight loss treatment permanently. If you're trying to understand what they are, how they work, and whether they might be right for you — start here.
The gaunt, aged appearance some people develop during rapid weight loss on GLP-1 medications has a name — and it's not inevitable. Understanding why it happens is the first step to preventing it.
Nausea, constipation, fatigue, hair changes — GLP-1 medications come with real side effects. Most are manageable and temporary. Here's what to expect and what to do about each one.